Fmoc L-(1-adamantyl)glycine(1221793-29-8)
- Name: Fmoc L-(1-adamantyl)glycine
- Synonyms:
- Molecular Formula:
- Molecular Weight:431.532
- CAS Registry Number:1221793-29-8
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1221793-29-8 N-Fmoc-L-adamantylglycine
Assay:98% Package:25 kgs Packed in Drum,small order in carton Packing Storage:Store in cool and dry place, away from Sun light. Transportation:By Express,By Sea or by Air Application:Amino Acids
Min. Order:1Kilogram
Supplier:Xi'an HDM Biotech Co., Ltd. [
China (Mainland)] CAS No.1221793-29-8 (S)-Fmoc-1-adamantyl-glycine;1221793-29-8
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Min. Order:10Metric Ton
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] CAS No.1221793-29-8 (S)-Fmoc-1-adamantyl-glycine
Package:As client requirement Transportation:Express, Air , Sea shipment Application:Pharmaceutical Intermediates
Min. Order:0
Supplier:Hunan chemfish Pharmaceutical co.,Ltd [
China (Mainland)] CAS No.1221793-29-8 N-Fmoc-L-adamantylglycine
Assay:95% Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 1404441-76-4/C16H24BrN3O2
- 1416311-92-6/1-(2,2-dimethylpropyl)-3-methyl-5-[1-(phenylsulfonyl)piperidin-3-yl]-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one
- 1416794-86-9/(S)-2-methyl-N-((4-(trifluoromethyl)phenyl)(3-(trifluoro-methyl)pyridin-2-yl)methyl)isonicotinamide
- 1415966-03-8/N-(2,4,6-trimethylphenyl)disilazane
- 1095657-77-4/2-Chloro-N-(2-(4-fluorophenyl)propan-2-yl)quinazolin-4-amine
- 1095660-20-0/N-(2-Chlorobenzyl)-2-(piperidin-1-yl)quinazolin-4-amine
- 1257693-72-3/C19H24ClN7O
- 1173240-77-1/5-fluoro-6-[1-(2,3,6-trichlorophenyl)ethoxy]-1,3-benzothiazol-2-amine
- 1253041-45-0/C10H17NO5
- 955971-46-7/1-[9-[(1R,2S,3R,4S)-2,3-dihydroxy-4-(2-hydroxy-acetylamino)-cyclopentyl]-6-(2,2-diphenyl-ethylamino)-9H-purin-2-yl]-1H-pyrazole-4-carboxylic acid (3-sulfamoyl-phenyl)-amide
- 951033-49-1/7-acryloyl-N-(3-ethynylphenyl)-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amine
- 951034-73-4/N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-7-[(2E)-5-(dimethylamino)pent-2-enoyl]-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amine
- 1258460-49-9/C24H19F4N3O2S
- 1178881-71-4/3-isopropyl-N-{1-[(1-methyl-1H-imidazol-4-yl)sulfonyl]-3-phenylpiperidin-3-yl}-1H-pyrazole-5-carboxamide
- 1175085-90-1/[1-(3-ethynyl-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4yl]-(3,4,5-trimethoxy-benzyl)-amine
- 1258070-55-1/2-[[methyl-[[2-(trifluoromethyl)-phenyl]sulfonyl]-amino]-methyl]-3H-benzoimidazole-5-carboxylic acid methyl ester
- 1262618-75-6/2-methyl-2-{4-[3-(trifluoromethyl)[1,2,4]triazolo[4,3-a]pyridin-6-yl]phenyl}propanenitrile
- 1246663-90-0/C18H12N4O2
- 1246663-51-3/C21H16F3N3O3
- 1221793-29-8/Fmoc L-(1-adamantyl)glycine
- 1146358-23-7/C22H25FN6O2S
- 1202378-33-3/C26H22FNO2
- 1173792-38-5/C22H26ClN7O2
- 1260099-27-1/4-(2-{4-[3-((R)-2-methyl-pyrrolidin-1-yl)-propoxy]-phenyl}-2-oxo-ethyl)-piperazine-1-carboxylic acid isopropyl ester
- 1192427-13-6/C18H26N4O2S
- 1260486-91-6/C22H21ClF2O2
- 1262196-17-7/N-[3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-1-methyl-1H-1,2,4-triazol-5-yl]-6-methyl 3-pyridinamine
- 1262844-78-9/N-(1-cyano-cyclopropyl)-3-{5-[4-(4-methylpiperazin-1-yl)phenyl]-1H-pyrazol-3-yl}benzamide
- 1262756-27-3/C35H38F2N4O2S
- 1263402-28-3/3-((1-cyclopropyl-2-oxopyrrolidin-3-yl)oxy)-5-(4-(5-methyl-1,3,4-oxadiazol-2-yl)phenoxy)-N-(4-methylthiazol-2-yl)benzamide